Home >> ALL ISSUES >> 2016 Issues >> Put It on the Board, 8/16

Put It on the Board, 8/16

image_pdfCreate PDF

 

LabCorp will acquire Sequenom

New York ends state PT services

St. Jude lands CAP ISO 15189 accreditation

Epigenomics’ DNA test included in CRC guideline

OSU to deploy Inspirata digital pathology solution

Mindray’s clinical chemistry analyzer cleared

Successful Keytruda trial stopped early

Top court clarifies autopsy’s place in Texas law

EUA for Siemens Zika assay

LabCorp will acquire Sequenom

Laboratory Corp. of America and Sequenom have entered into a definitive agreement and plan of merger under which LabCorp would acquire all of the outstanding shares of Sequenom in a cash tender offer for $2.40 per share, or an equity value of $302 million, which represents a total enterprise value of about $371 million, including net indebtedness.

“This is exactly the kind of strategic acquisition that LabCorp seeks,” David King, the company’s chairman and CEO, said in a statement. Sequenom was the first laboratory to offer a clinically validated noninvasive prenatal test, MaterniT21, and has performed more than 500,000 tests to date, King said. “Sequenom’s proven best-in-class technology and strong research complement LabCorp’s extensive women’s health offering, providing patients and physicians with one source for the most complete range of testing options in women’s health, including NIPT and reproductive genetics.” The acquisition is expected to close by year’s end.
[hr]

CAP TODAY
X